stonks4u
Sign up free
WVE logo

WVE Wave Life Sciences Ltd.

NASDAQ · Biotechnology · Healthcare

$5.41
+0.21 (+4.04%)

Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The company’s medicines platform, PRISM combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disor…

Market Cap: $1.07Bwavelifesciences.com

Price (90d)

No price history yet — the daily price refresh runs once a day.

Signal Score (90d)

120
8093107120
Aug 10Aug 13

Quote

Day Range
$5.14 – $5.42
52-Week Range
$5.01 – $21.73
Volume
$2.88M
Market Cap
$1.07B
50-Day Avg
$5.87
200-Day Avg
$9.50
Prev Close
$5.20
Open
$5.16

Valuation & Ratios

P/E Ratio
-14.05
EPS
$-1.21
P/B Ratio
5.45
P/S Ratio
67.10
Debt/Equity
0.03
Current Ratio
6.47
Dividend Yield
+0.0%
Gross Margin
+79.3%

Returns & Efficiency

Return on Equity
-38.8%
Return on Assets
-32.0%
FCF Yield
-6.5%
EV/EBITDA
-11.67

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$42.73M$-204.38M$-1.21
2024$108.30M$-97.01M$-0.70
2023$113.31M$-57.51M$-0.54
2022$3.65M$-161.82M$-2.05
2021$40.96M$-122.25M$-2.36

Social Signal Score

61
5d
71
2 mentions
—
30d
58
3 mentions
—
60d
58
3 mentions
—
90d
58
3 mentions
—
news: 3

Earnings

Mon, Nov 9(in 3 months)

Consensus estimate $-0.33 per share

2of 7 quarters beat consensus

Typical surprise -6.9% (median, so one quarter with a near-zero estimate can't distort it)

  • Thu, Jul 30$-0.34 vs $-0.30miss
  • Tue, Apr 28$-0.13 vs $-0.34beat
  • Thu, Feb 26$-0.30 vs $-0.28miss
  • Mon, Nov 10$-0.32 vs $-0.30miss
  • Wed, Jul 30$-0.31 vs $-0.29miss
  • Thu, May 8$-0.29 vs $-0.27miss

Estimates and results for WVE via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Valuation

WVEhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.

Mentions (3)

  • News247wallst.com·2d ago·Positive

    Wave Life Sciences: A $1 Billion RNA-Medicine Bargain Ripe for Pharma Takeover Wave Life Sciences (NASDAQ:WVE) trades at $5.24, a step above its 52-week low of $5.01 and far beneath the 52-week high of $21.73.

    View source ↗
  • Newsseekingalpha.com·3d ago·Positive

    Wave Life Sciences Ltd. (WVE) Presents at Bank of America SMID Cap Virtual Conference Transcript Wave Life Sciences Ltd. (WVE) Presents at Bank of America SMID Cap Virtual Conference Transcript

    View source ↗
  • Newsglobenewswire.com·5d ago·Negative

    Wave Life Sciences Announces Completion of Redomiciliation to Delaware CAMBRIDGE, Mass., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences, Inc. (NASDAQ: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health (“Wave” or “Wave Life Sciences”), today announced the completion of the redomiciliation process to change the parent company of the Wave group of companies from a Singapore company to a Delaware corporation by way

    View source ↗